(Circulation. 1995;91:1375-1380.)
© 1995 American Heart Association, Inc.
Articles |
From the Cardiovascular Research Institute, University of California, San Francisco.
Correspondence to Mary J. Malloy, MD, Box 0130, University of California at San Francisco, San Francisco, CA 94143.
| Abstract |
|---|
|
|
|---|
Methods and Results In 197 asymptomatic subjects with FH, we examined the prevalence of ectasia and its association with coronary risk factors. An ectatic segment was defined as one with a luminal diameter >1.5 times that of the adjacent normal segment, excluding poststenotic dilation. Among subjects with FH, 15% had ectasia compared with 2.5% of an age- and sex-matched control group of 198 subjects without FH pre- senting for coronary angiography (P<.001). These control patients had significantly more severe coronary atherosclerosis than patients with FH. Ectasia was 3 times more common in men than women (P<.025). Neither age nor hypertension was predictive. Although in part reflecting the striking sex differential, ectasia was strongly associated with a lower HDL cholesterol level (P=.003), a higher LDL/HDL ratio (P=.003), and to a lesser extent, a higher LDL cholesterol level (P=.07). No association was found with plasma triglycerides or very low-density lipoprotein cholesterol levels. Among FH patients, ectasia was strongly associated with an overall index of occlusive atherosclerotic disease, based on quantitative angiography (P=.004). Intracoronary ultrasound interrogation of aneurysmal segments revealed circumferential intimal thickening.
Conclusions Coronary ectasia is more prevalent in patients with FH than in other patients with coronary atherosclerosis and shows a strong inverse association with HDL cholesterol levels. This suggests that disordered lipoprotein metabolism in FH may predispose patients to aneurysmal coronary artery disease.
Key Words: hypercholesterolemia lipoproteins aneurysm risk factors angiography
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
Angiography and Analysis of Angiograms
Coronary angiography
was done via the femoral arterial approach
using 7F catheters (US Catheter Instrument Co). Cineangiograms were
filmed at 60 frames per second through a lens with a focal length of
135 mm, with an x-ray field of 15 cm. Multiple pairs of perpendicular
views of the left and right coronary arteries were obtained for biplane
quantitative analysis.17
Films were viewed at x5 magnification (Vanguard Instruments). An ectatic segment was defined as one with a luminal diameter >1.5 times that of the adjacent normal segment.18 Poststenotic dilation was excluded from this analysis. Ectatic segments were classified as localized when they involved a discrete portion of the artery with adjacent normal vessel within that segment and diffuse when the entire segment was ectatic with no normal vessel within that segment. Measurements were made using a calibration device placed perpendicular to the artery of interest, and in each instance, an ectasia ratio (diameter of ectatic segment/diameter of the adjacent normal segment) was calculated.
In 141 patients with FH, percent cross-sectional area stenosis was computed using quantitative angiography.17 As an index of severity of coronary artery disease, a coronary stenosis score was also calculated in each patient as the sum of all percent area coronary stenoses. Angiograms were also analyzed for percent diameter stenosis and number of lesions. In addition, angiograms from 198 patients from our catheterization laboratory, matched for age and sex with the FH population, were analyzed for evidence of coronary ectasia and for percent diameter stenosis and number of lesions.
Measurement of Lipids and Lipoproteins
Close to the time of
angiographic evaluation, blood was drawn
from patients after a 10- to 16-hour fast. Serum was separated at room
temperature for determination of cholesterol and triglyceride
concentrations.19 Cholesterol and triglyceride
concentrations were measured as very low-density lipoproteins (VLDL),
low-density lipoproteins, and high-density lipoproteins after
separation by preparative ultracentrifugation.19
Cholesterol and triglyceride analyses were standardized against
reference material supplied by the Standardization of the National
Center for Disease Control.
Intravascular Ultrasound Imaging
In two subjects with
ectasia, intravascular ultrasound imaging
was performed as previously described20 to examine the
characteristics of the arterial wall in the ectatic segment. In brief,
a 4.3F, 30-MHz, two-dimensional ultrasound imaging catheter
(Cardiovascular Imaging Systems) was introduced over a 0.014-in. guide
wire into the arterial segment of interest. Two-dimensional ultrasound
images were obtained using a commercially available imaging system
(CVIS, Cardiovascular Imaging Systems). The ultrasound catheter (4.3F)
has a fixed, 30-MHz transducer and a rotating mirror assembly. Images
were displayed on a video monitor; axial resolution was approximately
150 µm and lateral resolution approximately 250 µm. Gain, contrast,
and reject settings were adjusted by the operator to yield a
well-balanced gray scale appearance on the video display. Real-time
images were stored on high-quality super VHS videotape for subsequent
off-line studies.
Statistical Analysis
The prevalence of ectasia in FH patients
was compared
with those without FH using a 2x2
2
analysis. Tests of normality were applied, and since most of the
data were found not to be normally distributed, nonparametric
comparisons were applied. Coronary risk factors between FH patients
with ectasia and FH patients without ectasia were compared using the
Mann-Whitney U test. Sex and ethnic distributions and
prevalence of hypertension and smoking in the FH groups with and
without ectasia were compared using a 2x2
2
analysis. Potential correlations between coronary risk factors and
the degree of ectasia were examined using the Kendall correlation
test.
| Results |
|---|
|
|
|---|
2=14.37, P<.001). Whereas the study
population with FH had nearly equal numbers of men (n=95) and women
(n=102), ectasia was about 3 times as common in men with FH (21 men, 8
women,
2=4.99, P=.025).
Age, Hypertension, Smoking, and Ethnicity
There was no
apparent relation of ectasia to age, hypertension,
smoking, or ethnicity. Mean age in the FH group with ectasia was
42.5±1.8 years and 42.6±0.9 in the group without ectasia. There
was
one hypertensive patient in the FH group with ectasia and 15 in the FH
group without ectasia (
2=0.99, P=NS).
There were 10 smokers among the group with ectasia (only 2 were current
smokers) and 57 among the FH patients without ectasia (10 current)
(
2=0.003, P=NS). The majority of
patients in both groups were white (ectasia, 59%; no ectasia, 69%),
and ethnic distributions in the two groups were similar.
Anatomic Distribution and Type of Ectasia in the Coronary
Arteries
Twenty-one patients had ectasia in the right coronary artery
(13
diffuse, 8 localized), 16 had ectasia involving the left anterior
descending coronary artery (10 localized, 6 diffuse), 13 had ectasia of
the circumflex coronary artery (9 diffuse, 4 localized) (Figs 1
and 2
), and 2 had ectasia involving the left
main coronary artery (both diffuse).
|
|
Lipoprotein Levels: Association With Coronary Ectasia
HDL
cholesterol levels were significantly lower (ectasia,
47.2±2.6; no ectasia, 55.8±1.2 mg/dL; P=.003),
LDL
cholesterol levels higher (ectasia, 322.3±14.6; no ectasia,
296.3±5.5
mg/dL; P=.07), and LDL/HDL ratios significantly higher
(ectasia, 7.4±0.5; no ectasia, 5.9±0.2; P=.003)
in FH
patients with ectasia (Fig 3
). There was no significant
difference between groups in total cholesterol (ectasia, 406.8±15.1;
no ectasia, 395.9±5.8 mg/dL), total triglycerides (ectasia,
128.1±12.3; no ectasia, 132.0±8.2 mg/dL), LDL triglycerides
(ectasia,
41.7±3.4; no ectasia, 42.6±1.6 mg/dL), HDL triglycerides
(ectasia,
13.3±1.0; no ectasia, 13.9±0.5 mg/dL), VLDL cholesterol
(ectasia,
22.8±2.9; no ectasia, 23.7±1.8 mg/dL), or VLDL triglycerides
(ectasia, 69.0±9.1; no ectasia, 69.0±6.6 mg/dL).
|
Whereas LDL cholesterol levels were similar in men and women in our FH study population (men, 299.5±7.0; women, 300.7±7.7 mg/dL), HDL cholesterol levels were significantly higher in women (men, 47.9±1.4; women, 60.6±1.6; P<.001). This no doubt partially accounts for our finding of lower HDL cholesterol levels in FH patients with ectasia, where the male-to-female ratio was almost 3:1. However, women with ectasia also had lower HDL cholesterol levels (52.9±7.6 mg/dL) than women without ectasia (61.3±1.6 mg/dL) (P=.07). Men with ectasia, too, showed a trend toward lower HDL cholesterol levels (45.1±2.1 mg/dL) compared with men without ectasia (48.7±1.6 mg/dL), but this difference did not reach statistical significance in our limited sample. The degree of ectasia (defined as the ratio of the ectatic segment to the adjacent nonectatic segment) ranged from 1.5 to 4.4 in patients with FH and did not correlate significantly with age or lipoprotein concentrations.
The 5 control subjects with ectasia had a mean total cholesterol level of 203±6.5 mg/dL, suggesting that none of these subjects had FH.
Coronary Artery Stenosis: Association With Ectasia
In 141 FH
patients (ectasia, 16; no ectasia, 125) whose angiograms
were analyzed for coronary stenosis by quantitative angiography,
composite within-patient coronary stenosis scores correlated
significantly with age (P<.001), total cholesterol
(P=.04), LDL cholesterol (P=.04), and LDL/HDL
cholesterol ratios (P=.03). There was a significantly higher
coronary stenosis score in FH patients with ectasia (ectasia, 148±17;
no ectasia, 103±5; P=.004), and there was a significant
correlation between the coronary stenosis score and the number of
ectatic vessels (P=.003).
Overall, patients with FH had less severe coronary artery disease than the control population. The average number of lesions in patients with FH was 5.8±0.4, with a mean percent diameter stenosis of 34±2%; control patients without ectasia had a mean of 6.2±0.3 lesions, with a mean percent diameter stenosis of 51±1.4%.
Intravascular Ultrasound Imaging Studies
In two patients with
ectasia, the ectatic segment also was
examined using two-dimensional intravascular ultrasound imaging.
Despite angiographic evidence of increase in lumen size, the ectatic
segments showed circumferential intimal thickening (Fig 4
),
with a mean intimal thickness of 900 µm. This
value for intimal thickness is considerably in excess of the normal
range (<178 µm) previously reported from our
laboratory.21
|
| Discussion |
|---|
|
|
|---|
Coronary ectasia was 3 times more frequent in men than in women in our study. Men are known to have a lower HDL cholesterol than women; hence, the association of a lower HDL in FH patients with ectasia may have been caused by a higher male-to-female ratio among patients with ectasia in our study. However, HDL cholesterol levels were lower among our female FH patients with coronary ectasia and tended to be lower in male FH patients with ectasia as well. There was no difference in LDL cholesterol levels between men and women among our FH patients. Hence, our observation of higher LDL levels in FH patients with ectasia was unlikely to have been biased by the increased number of male FH patients with ectasia. Our findings differ from those of Genda et al,16 who found no association of ectasia with lipoprotein levels or coronary stenosis.
Our observation that ectasia of the coronary arteries correlated with the severity of stenotic coronary lesions (in within-patient studies) suggests that stenosis and ectasia have pathophysiological mechanisms in common. In fact, thinning of the vascular media has been associated with advanced atherosclerosis.23 24 Because we systematically excluded ectatic regions that were juxtaposed to stenotic lesions, the phenomenon we have observed is not due to poststenotic dilation. Glagov and his associates25 have described compensatory dilation in human coronary arteries at sites where plaques have begun to diminish the cross-sectional area of the lumen. This involves an increase in the area inscribed by the internal elastic lamina, indicating that this structure is somehow capable of expansion at the site of the lesion. Observations in animal models suggest that this phenomenon is related to increased velocity of flow in the vicinity of the plaque.26 27 Whatever the mechanism, the capacity for compensatory dilation appears to be limited, ceasing when plaque volume reaches about 40% of the area within the internal elastic lamina.25 Schwartz et al have shown that age itself appears to produce significant dilation of both the coronary arteries28 and the aorta,29 perhaps reflecting long-term mechanical effects on elastic tissue elements. The dilation associated with age, however, is uniform in its distribution and limited to an increase of about twofold in luminal diameter, in contrast with the focal, often saccular, aneurysms that we describe. Thus, if a commonality of mechanism is involved with the phenomenon of dilation with age, it is markedly aggravated in patients with FH.
FH is associated with the highest levels of LDL among the more common forms of genetic hyperlipidemia. Therefore, the marked increase that we have observed in the incidence of coronary ectasia among patients with FH and its positive correlation with LDL cholesterol levels in this study suggest that lipoproteins may be directly involved in this process, perhaps reducing the tensile strength of the artery wall. Thompson et al30 reported improvement in coronary ectasia after plasma exchange in a patient with FH, lending support to an association between plasma lipoproteins and ectasia. Interestingly, lipid abnormalities have been described in Kawasaki syndrome,31 which is associated with coronary artery abnormalities including aneurysms.12 The abnormal lipid profile includes depressed total and HDL cholesterol concentrations during the acute phase and a persistence of low HDL for many years.31 The association of these abnormalities with coronary ectasia in Kawasaki syndrome has not been studied.
Physical interaction between lipoprotein-like particles and both elastin and collagen fibers can be demonstrated by scanning electron microscopy.32 Apolipoprotein (apo) B, the principal protein of LDL, can be detected immunochemically in the vicinity of collagen and elastin fibers in the intima. Furthermore, it has long been recognized that about half of the apo Bcontaining lipoproteins of the artery wall are released only after collagenase treatment. LDL has been shown to bind to both elastin33 and collagen34 in vitro, and lipoprotein-derived lipids can themselves bind to collagen.35 In fact, this process may be an integral part of the formation of foam cells because it has been shown that interaction of LDL with collagen and with elastin increases endocytosis by macrophages and smooth muscle cells.36 37 In this respect, it is interesting that the binding of LDL to collagen may induce conformational changes in apo B that facilitate its binding to collagen-like domains of the scavenger receptor.38 Furthermore, oxidation of LDL, now thought to be a critical process in atherogenesis,39 increases binding of LDL to collagen,40 raising the possibility of damage to collagen or elastin fibers mediated by free radicals derived from lipid hydroperoxides and other reactive intermediaries. A further mechanism by which collagen could be chemically modified is the covalent cross-linking of apo B to arterial type III procollagen by transglutaminase.41
In addition to the possibility that structural weakening of connective tissue elements in the artery wall may result from interaction with LDL, active lysis of elastin or collagen also may be a consequence of foam cell formation. Fuster et al42 and Schwartz et al43 have pointed out the inflammatory nature of the atheroma. In particular, unstable angina and infarction are now clearly established consequences of the weakening of the connective tissue scaffolding underlying the endothelium over an atheromatous plaque.42 44 The frequent appearance of layers of fibrin incorporated into complex lesions suggests that such events are commonplace, contributing to the mass of atheroma as a result of subclinical fissuring. A direct link between foam cells and possible weakening of arterial wall connective tissue is already at hand. Macrophages elaborate several proteases, including collagenase activity, as part of the inflammatory response. Furthermore, it is now established that macrophages secrete elastase activity in response to the endocytosis of modified LDL.43 Endothelial injury also could contribute to this effect because platelet activating factor released by endothelial cells stimulates secretion of elastase activity by macrophages.45 Thus, coronary ectasia may be an exaggeration of the remodeling process. Our findings of circumferential intimal thickening at the ectatic site, on intracoronary ultrasound, is consistent with this model.
Although coronary ectasia has been reported in association with a variety of pathological conditions (see introduction), the most common association in Western populations is with atherosclerotic coronary artery disease.18 It is unlikely, however, that the greater prevalence of ectasia simply reflects greater severity of coronary artery disease because FH patients actually had less severe disease than the control population. The prognosis of patients with coronary ectasia is unclear. One study reported an increased mortality in association with ectasia,13 presumably from thrombosis secondary to nonlaminar blood flow in a dilated vessel. In that study, however, there was a higher incidence of three-vessel disease, which may have accounted for increased mortality. More recent studies2 have shown no increase in mortality for aneurysmal coronary artery disease. In the present study, ectasia in FH patients is associated with a more abnormal lipoprotein profile and with more severe atherosclerosis and thus would predict a higher risk of mortality. Further follow-up of these patients is required to reveal the pathophysiological significance of this entity.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received December 22, 1993; revision received September 30, 1994; accepted October 10, 1994.
| References |
|---|
|
|
|---|
2.
Swaye PS, Fisher LD, Litwin P, Vignola PA, Judkins MP, Kemp
HG, Mudd JG, Gosselin AJ. Aneurysmal coronary artery disease.
Circulation. 1983;67:134-138.
3. Frithz G, Cullhed I, Bjork L. Congenital localized coronary artery aneurysm without fistula. Am Heart J. 1968;76:674-679. [Medline] [Order article via Infotrieve]
4. Daoud AS, Pankin D, Tulgan H, Florentin A. Aneurysms of the coronary artery. Am J Cardiol. 1963;11:228-237. [Medline] [Order article via Infotrieve]
5. Tunick PA, Slater J, Kronzon I, Glassman E. Discrete atherosclerotic coronary artery aneurysms: a study of 20 patients. J Am Coll Cardiol. 1990;15:279-282. [Abstract]
6. Denham SW. Syphilitic aneurysm of the left coronary artery. AMA Arch Pathol. 1951;51:661. [Medline] [Order article via Infotrieve]
7. Kirschner LP, Perloff JP, Twigg HL. Coronary artery ectasia in chronic cyanotic congenital heart disease. Med Ann. 1969;38:123-142.
8. Chaithiraphan S, Goldberg E, O'Reilly M, Jootar P. Multiple aneurysms of coronary artery in sclerodermal heart disease. Angiology. 1973;24:86-93.
9. Chamberlain JL, Perry LW. Infantile periarteritis nodosa with coronary and brachial aneurysms: a case diagnosed during life. J Pediatr. 1971;78:1039-1042. [Medline] [Order article via Infotrieve]
10. Imahori S, Bannerman RM, Graf CJ, Brennan JC. Ehlers-Danlos syndrome with multiple arterial lesions. Am J Med. 1969;47:967-977. [Medline] [Order article via Infotrieve]
11.
Crook BRM, Raftery EB, Oram S. Mycotic aneurysms of coronary
arteries. Br Heart J. 1973;35:107-109.
12. Kato H, Ichinose E, Yoshioka F, Takechi T, Matsunaga S, Suzuki K, Rikitake N. Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am J Cardiol. 1982;49:1758-1766. [Medline] [Order article via Infotrieve]
13. Markis JE, Joffe CD, Cohn PF, Feen DJ, Herman MV, Gorlin R. Clinical significance of coronary arterial ectasia. Am J Cardiol. 1976;37:217-222. [Medline] [Order article via Infotrieve]
14. Befeler B, Aranda J, Embi A, Mullin F, El-Sherif N, Lazzara R. Coronary artery aneurysms: study of their etiology, clinical course and effect on left ventricular function and prognosis. Am J Med. 1977;62:597-607. [Medline] [Order article via Infotrieve]
15. Mabuchi H, Michishita I, Sakai Y, Sakai T, Ikawa T, Genda A, Takeda R. Coronary ectasia in a homozygous patient with familial hypercholesterolemia. Atherosclerosis. 1986;59:43-46. [Medline] [Order article via Infotrieve]
16. Genda A, Nakayama A, Shimizu M, Nunoda S, Sugihara N, Suematzu T, Kita Y, Yoshimura A, Koizumi J, Mabuchi H, et al. Coronary angiographic characteristics in Japanese patients with heterozygous familial hypercholesterolemia. Atherosclerosis. 1987;66:29-36. [Medline] [Order article via Infotrieve]
17. Brown BG, Bolson EL, Dodge HT. Quantitative computer techniques for analyzing coronary arteriograms. Prog Cardiovasc Dis. 1986;28:408-418.
18.
Hartnell GG, Parnell BM, Pridie RB. Coronary artery ectasia:
its prevalence and significance in 4993 patients. Br Heart
J. 1985;54:392-395.
19. Myers LH, Phillips NR, Havel RJ. Mathematical evaluation of methods for estimation of the concentration of the major lipid components of human serum lipoproteins. J Lab Clin Med. 1976;88:491-505. [Medline] [Order article via Infotrieve]
20.
Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized
calcium deposits to dissection after angioplasty: an observational
study using intravascular ultrasound. Circulation. 1992;86:64-70.
21.
Fitzgerald PJ, St. Goar FG, Connolly AJ, Pinto FJ, Billingham
ME, Popp RL, Yock PG. Intravascular ultrasound imaging of coronary
arteries: is three layers the norm? Circulation. 1992;86:154-158.
22. Aparici M, Peteiro J, Fernandez de Almeida CA, Hidalgo R, Alzamora P, Barba J, Alegria E. Coronary ectasia: another form of atherosclerosis. Med Clin. 1989;7:368-371.
23. Isner JM, Donaldson RF, Fortin AH, Tischler A, Clarke RH. Attenuation of the media of coronary arteries in advanced atherosclerosis. Am J Cardiol. 1986;58:937-939. [Medline] [Order article via Infotrieve]
24. Gussenhoven EJ, Frietman PAV, The SHK, van Suylen RJ, van Egmond FC, Lancee CT, van Urk H, Roelandt JRTC, Stijnen T, Bom N. Assessment of medial thinning in atherosclerosis by intravascular ultrasound. Am J Cardiol. 1991;68:1625-1632. [Medline] [Order article via Infotrieve]
25. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316:1371-1375. [Abstract]
26.
Kamiya A, Togawa T. Adaptive regulation of wall shear stress
to flow change in the canine carotid artery. Am J Physiol. 1980;239:H14-H21.
27. Zarins CK, Zatina MA, Giddens DP, Ku DN, Glagov S. Shear stress regulation of artery lumen diameter in experimental atherogenesis. J Vasc Surg. 1987;5:413-420. [Medline] [Order article via Infotrieve]
28. Schwartz CJ, Ardlie NG. Observations on the natural history of coronary artery disease. Aust Ann Med. 1966;15:101-105.
29. Schwartz CJ, Ardlie NG, Carter RF, Paterson JC. Gross aortic sudanophilia and hemosiderin deposition: a study on infants, children, and young adults. Arch Pathol. 1967;83:325-332. [Medline] [Order article via Infotrieve]
30.
Thompson GR, Myant NB, Kilpatrick D, Oakley CM, Raphael MJ,
Steiner RE. Assessment of long-term plasma exchange for familial
hypercholesterolemia. Br Heart J. 1980;43:680-688.
31.
Newburger JW, Burns JC, Beiser AS, Loscalzo J. Altered lipid
profile after Kawasaki syndrome. Circulation. 1991;84:625-631.
32. Pasquinelli G, Preda P, Vici M, Gargiulo M, Stella A, D'Addato M, Laschi R. Electron microscopy of lipid deposits in human atherosclerosis. Scanning Microsc. 1989;3:1151-1159. [Medline] [Order article via Infotrieve]
33.
Podet EJ, Shaffer DR, Gianturco SH, Bradley WA, Yang CY,
Guyton JR. Interaction of low-density lipoproteins with human aortic
elastin. Arterioscler Thromb. 1991;11:116-122.
34. Camejo G. The interaction of lipids and lipoproteins with the intracellular matrix of arterial tissue: its possible role in atherogenesis. Adv Lipid Res. 1982;19:1-53. [Medline] [Order article via Infotrieve]
35. LeLous M, Boudin D, Salmon S, Polonovski J. The affinity of type 1 collagen for lipid in vitro. Biochem Biophys Acta. 1982;708:26-32.
36. Grande J, Davis HR, Bates S, Mathews MB, Glagov S. Effect of an elastin growth substrate on cholesteryl ester synthesis and foam cell formation by cultured aortic smooth muscle cells. Atherosclerosis. 1987;68:87-93. [Medline] [Order article via Infotrieve]
37. Yla-Herttuala S, Jaakkola O, Solakivi T, Kuivaniemi H, Nikkari T. The effect of proteoglycans, collagen and lysyl oxidase on the metabolism of low density lipoprotein by macrophages. Atherosclerosis. 1986;62:73-80. [Medline] [Order article via Infotrieve]
38.
Matsumoto A, Naito M, Itakura H, Ikemoto S, Asaoka H, Hayakawa
I, Kanomori H, Aburatani H, Takaku F, Suzuki H, et al. Human macrophage
scavenger receptors: primary structures, expression and localization in
atherosclerotic lesions. Proc Natl Acad Sci U S A. 1990;87:9133-9137.
39.
Parthasarathy S, Printz DJ, Boyd D, Joy L, Steinberg D.
Macrophage oxidation of low density lipoprotein generates a modified
form recognized by the scavenger receptor. Arteriosclerosis. 1986;6:505-509.
40.
Hoover GA, McCormick S, Kalant S. Interaction of native and
cell-modified low-density lipoprotein with collagen gel.
Arteriosclerosis. 1988;8:525-534.
41. Bowness JM, Tarr AH, Wiebe RI. Transglutaminase-catalysed cross-linking: a potential mechanism for the interaction of fibrinogen, low-density lipoprotein and arterial type III procollagen. Thromb Res. 1989;54:357-367. [Medline] [Order article via Infotrieve]
42. Fuster V, Badimon L, Badimon JJ, Chesebro JH. Mechanisms of disease: the pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250,310-318. [Medline] [Order article via Infotrieve]
43. Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Nerem RM. The pathogenesis of atherosclerosis: an overview. Clin Cardiol. 1991;14:I-1-I-16.
44. Fuster V, Stein B, Ambrose JA, Badimon L, Badimon JJ, Chesebro JH. Atherosclerotic plaque rupture and thrombosis. Circulation. 1990;82(suppl II):II-47-II-59.
45.
Bussolino F, Camussi G, Baglioni C. Synthesis and release of
platelet-activating factor by human vascular endothelial cells treated
with tumor necrosis factor or interleukin 1 alpha. J Biol
Chem. 1988;263:11856-11861.
This article has been cited by other articles:
![]() |
Y Gunes, B Boztosun, A Yildiz, A Metin Esen, M Saglam, M Bulut, H Karapinar, and C Kirma Clinical profile and outcome of coronary artery ectasia. Heart, August 1, 2006; 92(8): 1159 - 1160. [Full Text] [PDF] |
||||
![]() |
A. Manginas and D. V. Cokkinos Coronary artery ectasias: imaging, functional assessment and clinical implications Eur. Heart J., May 1, 2006; 27(9): 1026 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Reddy, S. K. G. Koshy, S. Wasson, E. E. Quan, S. Pagni, A. M. Roberts, I. G. Joshua, and S. C. Tyagi Adaptive-Outward and Maladaptive-Inward Arterial Remodeling Measured by Intravascular Ultrasound in Hyperhomocysteinemia and Diabetes Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2006; 11(1): 65 - 77. [Abstract] [PDF] |
||||
![]() |
A. I. Papathanasiou, C. S. Katsouras, I. A. Goudevenos, L. K. Michalis, K. Achenbach, and D. A. Sideris Rare Association of Diffused Coronary Ectasia and Anomalous Origin of Left Circumflex Coronary Artery in a Man with Heterozygous Familial Hypercholesterolemia: A Case Report Angiology, May 1, 2005; 56(3): 343 - 345. [Abstract] [PDF] |
||||
![]() |
J.-J. Li, M.-Z. Chen, and X. Chen A Pedigree Analysis of Familial Hypercholesterolemia in Monozygote Twin Brothers Angiology, November 1, 2003; 54(6): 711 - 713. [Abstract] [PDF] |
||||
![]() |
P. Nyamu, M. S Ajit, P. K Joseph, L. Venkitachalam, and N. A Sugirtham The Prevalence and Clinical Profile of Angiographic Coronary Ectasia Asian Cardiovasc Thorac Ann, June 1, 2003; 11(2): 122 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Chakrabarti, E Thomas, J G C Wright, and J J Vettukattil Congenital coronary artery dilatation Heart, June 1, 2003; 89(6): 595 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Galis and J. J. Khatri Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: The Good, the Bad, and the Ugly Circ. Res., February 22, 2002; 90(3): 251 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.T Real, F.J Chaves, I Martinez-Uso, A.B Garcia-Garcia, J.F Ascaso, and R Carmena Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia Eur. Heart J., March 2, 2001; 22(6): 465 - 471. [Abstract] [PDF] |
||||
![]() |
M. R. Ward, G. Pasterkamp, A. C. Yeung, and C. Borst Arterial Remodeling : Mechanisms and Clinical Implications Circulation, September 5, 2000; 102(10): 1186 - 1191. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |